• Use of recombinant human glutamic acid decarboxylase (GAD65)
• Ready-to-use (exception: wash buffer), color- and barcoded reagents
• Quality assured handling in routine laboratories
• Incubation at room temperature
• Quantitative determination of antibodies against GAD65)
• Calibrated with the international standard preparation NIBSC code 97/550
• Results expressed in IU/mL
• Excellent diagnostic sensitivity and specificity
• High precision within the measurement range
• CE marked
• Fully automatable
3507 – Medizym® anti-GAD M
Autoimmunity, Diagnostics, ELISA
3507 – Medizym® anti-GAD M
Enzyme immunoassay for the quantitative determination of antibodies against Glutamic Acid Decarboxylase (GAD65) in human serum
Available Downloads:
| Indication | Diabetes mellitus Type 1 |
|---|---|
| Format | Microtiter plate coated with recombinant human GAD65 |
| Total incubation time | 160 min. |
| No. of determinations | 96 (89 x 1) + 6 x Calibrators and 1 x Control |
Related products
-
3665 – Anti-CCP
Enzyme immunoassay for the quantitative determination of IgG antibodies against cyclic citrullinated peptides (CCP) in human serum
-
8063 – CytoBead® ANCA
The CytoBead® ANCA is an immunofluorescence assay (IFA) for the qualitative and semi-quantitative determination of IgG antibodies in human serum against neutrophil cytoplasmic antigens (ANCA) and the glomerular basal membrane (GBM). The CytoBead® ANCA is is intended as an aid in the diagnosis of systemic vasculitis as well as autoimmune renal disorders in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.
-
8101, 81040 – ANA HEp-2 plus
Immunofluorescence assay (IFA) for the determination of IgG antibodies against nuclear and cytoplasmic antigens (ANA) in human serum